Journal of Infectious Disease and Pathology
Open Access

Dengue hemorrhagic fever; Risk factors; Adults; Dengue virus; Secondary infections; Pre-existing health conditions

Introduction

Dengue hemorrhagic fever (DHF), caused by the dengue virus and transmitted by Aedes mosquitoes, is a significant global health concern. While dengue fever is typically self-limiting, DHF can escalate rapidly, leading to severe bleeding, plasma leakage, and organ failure, ultimately resulting in death. Adults, in particular, face an elevated risk of experiencing lethal DHF, necessitating a comprehensive investigation into the underlying risk factors that contribute to its severity [1,2].

This article delves into the multifaceted nature of lethal DHF in adults, examining a range of risk factors that can significantly impact its outcome. By elucidating these risk factors, we aim to provide healthcare professionals, researchers, and policymakers with critical insights that can inform early diagnosis, improved patient care, and the development of targeted preventive measures.

Dengue hemorrhagic fever (DHF) is a potentially life-threatening complication of dengue virus infection, characterized by severe bleeding, plasma leakage, and organ failure. While dengue fever is usually a self-limiting illness, DHF can be fatal if not identified and managed promptly. The risk factors associated with lethal DHF in adults have been the subject of extensive research in recent years. Understanding these risk factors is crucial for improving early diagnosis, treatment, and prevention strategies. This article delves into the key risk factors associated with lethal dengue hemorrhagic fever in adults [3].

Age

Age is a significant determinant of disease severity in dengue. Research indicates that adults, especially those over 65, are more likely to develop severe forms of the illness. This increased vulnerability in older adults may be due to age-related changes in the immune system, making them less capable of mounting an effective defense against the virus [4].

Secondary infections

Secondary dengue infections pose a considerable risk. If an individual has previously been infected with one serotype and is subsequently exposed to a different serotype, the risk of developing DHF increases significantly. This phenomenon, known as antibodydependent enhancement (ADE), occurs when antibodies from the previous infection fail to neutralize the new serotype effectively, potentially leading to more severe disease.

Pre-existing health conditions

Underlying health conditions can exacerbate the risk of lethal DHF in adults. Conditions such as diabetes, hypertension, and immunosuppressive disorders weaken the body's immune response and increase the likelihood of severe dengue complications. These individuals often require closer monitoring and prompt medical intervention.

Delayed medical attention

Timely medical care plays a pivotal role in preventing the progression of dengue to its severe form. Adults who delay seeking medical attention when experiencing symptoms such as persistent vomiting, severe abdominal pain, bleeding, and rapid breathing face a heightened risk of developing lethal DHF. Early recognition and prompt treatment can significantly improve outcomes [5].

Socioeconomic factors

Socioeconomic factors also contribute to the risk of severe dengue. Individuals living in impoverished areas with limited access to healthcare facilities may encounter challenges in receiving timely and adequate medical care. Overcrowded living conditions and poor sanitation can further exacerbate the spread of the dengue virus.

Mosquito exposure

Exposure to Aedes mosquitoes, which are the primary vectors for dengue transmission, significantly impacts the risk of infection. Adults residing in or frequently visiting areas with high mosquito populations are more likely to contract the virus. Implementing effective mosquito control measures, such as the use of insect repellents and mosquito nets, can reduce this risk [6].

Immune response

The individual's immune response to the dengue virus is a critical factor. Some people may generate a robust and balanced immune response that successfully controls the virus. Others, however, may mount an exaggerated or dysfunctional response that contributes to severe symptoms, including plasma leakage and bleeding [7].

Discussion

The investigation into risk factors associated with lethal Dengue Hemorrhagic Fever (DHF) in adults has shed light on several critical aspects that influence the severity of this potentially life-threatening disease. These findings hold significant implications for both clinical management and public health interventions.

The research underscores the importance of age in predicting DHF severity in adults. Older individuals, particularly those over the age of 65, are more susceptible to severe forms of the disease. This age-related vulnerability may be attributed to age-related changes in the immune system, rendering older adults less capable of mounting an effective defense against the virus. These findings underscore the importance of targeted awareness campaigns and early diagnosis in older adult populations [8,9]. The presence of pre-existing health conditions, such as diabetes, hypertension, and immunosuppressive disorders, significantly increases the risk of severe DHF in adults. Patients with these underlying conditions often require more intensive monitoring and prompt medical intervention to manage the disease effectively. The integration of these factors into clinical decision-making is crucial for improving patient outcomes.

Timely medical care remains a critical factor in preventing the progression of dengue to severe and potentially lethal forms. Individuals who delay seeking medical attention when experiencing warning signs are at a heightened risk of developing lethal DHF. Efforts to educate the public and healthcare providers about these warning signs must be intensified to ensure early detection and intervention.

Reducing mosquito exposure through effective vector control measures, such as the use of insect repellents and mosquito nets, is crucial in reducing the risk of dengue infection. Additionally, a deeper understanding of individual immune responses to the dengue virus can help identify those at higher risk of severe disease and tailor interventions accordingly [10].

Conclusion

Investigating the risk factors associated with lethal Dengue Hemorrhagic Fever in adults has provided valuable insights into the complexity of this disease. By recognizing the various factors that contribute to disease severity, we can take significant steps toward improving patient outcomes and implementing targeted public health measures.

The findings emphasize the importance of early diagnosis, especially in older adults, and the need for healthcare systems to accommodate patients with pre-existing health conditions effectively. Furthermore, understanding the role of ADE in secondary infections is essential for vaccine development and therapeutic interventions.

Socioeconomic factors should not be underestimated, as they can significantly affect access to care and disease outcomes. Public health initiatives should prioritize equitable healthcare access and mosquito control efforts in vulnerable areas.

Ultimately, ongoing research into risk factors and their interplay in lethal DHF in adults is crucial for the development of comprehensive prevention and treatment strategies. As we continue to uncover the intricacies of this disease, we move closer to reducing the burden of Dengue Hemorrhagic Fever on global health.

Acknowledgement

None

Conflict of Interest

None

1. Lau EH, Hsiung CA, Cowling BJ, Chen CH, Ho LM, et al. (2010) A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect Dis 10: 1-9.

Indexed at, Google Scholar, Crossref

2. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States. N Engl J Med 361: 1935-1944.

Indexed at, Google Scholar, Crossref

3. Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: Convergence of two epidemics. Lancet Infect Dis 9: 737-744.

Indexed at, Google Scholar, Crossref

4. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80: 634-640.

Indexed at, Google Scholar, Crossref

5. Charlton MR, Pockros PJ, Harrison SA (2006) Impact of obesity on treatment of chronic hepatitis C. Hepatology 43: 1177-1186.

Indexed at, Google Scholar, Crossref

6. Lee MS, Hwang KP, Chen TC, Lu PL, Chen TP (2006) Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol Immunol Infect 39: 121-129.

Indexed at, Google Scholar

7. Burke DS, Nisalak A, Johnson DE, Scott RM (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.

Indexed at, Google Scholar, Crossref

8. Messer WB, Vitarana UT, Sivananthan K, Elvtigala J, Preethimala LD, et al. (2002) Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 66: 765-773.

Indexed at, Google Scholar, Crossref

9. Prompetchara E, Ketloy C, Thomas SJ, Ruxrungtham K (2020) Dengue vaccine: Global development update. Asian Pac J Allergy Immunol 38: 178-185

Indexed at, Google Scholar, Crossref

10. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, et al. (2004) Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 9: 1022-1029.

Indexed at, Google Scholar, Crossref